Broadfin Healthcare Master Fund Ltd, 10% Owner at Recro Pharma, Inc. (REPH), bought 650,000 shares at $6.00 ($3.9M) on 2016-12-13, disclosed to the SEC on 2016-12-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| REPH | SELL | 2017-12-14 | $1.5M | — | Filing → |
| REPH | SELL | 2017-12-07 | $1.0M | — | Filing → |
| PETX | SELL | 2017-12-01 | $5.1M | — | Filing → |